SYNTHESIS Materials and methods
NMR spectra were recorded on 500 MHz (500.0 MHz for 1 H, 202.3 MHz for 31 P, 125.7 MHz for 13 C) spectrometer from sample solutions in D2O or DMSO-d6. Chemical shifts (in ppm, δ scale) were referenced as follows: D2O (referenced to dioxane as internal standard: 3.75 ppm for 1 H NMR and 69.30 ppm 13 C NMR) and DMSO-d6 (referenced to solvent signal: 2.50 ppm for 1 H NMR and 39.70 ppm for 13 C NMR). Coupling constants (J) are given in Hz. Complete assignment of all NMR signals was achieved by using a combination of H,H−COSY, H,C-HSQC, and H,C-HMBC experiments. High resolution mass spectra were measured on a LTQ Orbitrap XL spectrometer (Thermo Fisher Scientific). Mass spectra of functionalized DNA were measured by MALDI-TOF, Reflex IV (Bruker) with nitrogen laser. The reactions were monitored by thin-layer chromatography using Merck silica gel 60 F254 plates and visualized at 254 nm. Column chromatography was performed using silica gel (40-63 μm). Semipreparative separation of nucleoside triphosphates was performed using HPLC on a column packed with 10 μm C18 reversed phase (Phenomenex, Luna C18 (2) 100 Å). Sample elution was monitored by its absorbance at 264 nm. Absorption spectra were measured on a Cary 100 UV-Vis spectrometer (Agilent Technologies). UV LEDs which were used for uncaging of modified PEX products XSL-355-E (5 mm; 353-360 nm; 0.8-1.2 mW; 1.06 mW/cm2), XRL400-5O (5 mm; 400-410 nm; 21.0-29.4 mW), VL425-5-15 (5 mm; 420-430 nm; 10-16 mW), were purchased from Roithner LaserTechnik. Synthetic oligonucleotides (primers, templates and biotinylated templates) were purchased from Generi Biotech. Natural nucleoside triphosphate (dATP, dCTP, dGTP, dTTP) were purchased from New England Biolabs. DNA polymerases were purchased from Merck (KOD XL) and from New England Biolabs (Vent exo-). Streptavidine magnetic particles were purchased from Roche. PCR products were purified using magnetic particles Agencourt AMPure XP. The PAGE gels were visualized by a fluorescence scanner (Typhoon FLA 9500, GE Healthcare).
3´, 5´-Bis-O-(tert-butyldimethylsilyl)-5-(2-nitrobenzyloxy)methyl-2´-deoxycytidine (2a)
Compound 1a (150 mg; 0.24 mmol), DMAP (35 mg; 0.29 mmol) and Et3N (350 µL; 2.5 mmol) were dissolved in anhydrous DCM (9 mL) and mixture was stirred for 10 minutes at room temperature. 2,4,6-Triisopropyl benzenesulfonyl chloride (350 mg, 1.16 mmol) was added and the reaction mixture was stirred at room temperature overnight under argon atmosphere. The solvent was removed under reduced pressure and the residue was dissolved in anhydrous dioxane. The flask with solution was evacuated three times and flushed with gaseous ammonia. The reaction mixture was stirred for 3 hours under gaseous ammonia at room temperature. After concentration in vacuum, the residue was purified by gradient column chromatography (gradient from 100% DCM to 25:1 DCM:MeOH) to yield protected 5-(2-nitrobenzyloxy)methyl-2´-deoxycytidine (120 mg; 80% over two steps).
The spectral data were in accordance with literature 1,2 .
5-(2-Nitrobenzyloxy)methyl-2´-deoxycytidine (dC NB )
Compound 2a (120 mg; 0.19 mmol) was dissolved in dry THF (9 mL), trimethylamine trihydrofluoride (100 µL; 0.61 mmol) was added and the reaction mixture was stirred overnight at room temperature. Then, another portion of trimethylamine trihydrofluoride (200 µL; 1.22 mmol) was added, and the stirring was continued overnight. The reaction mixture was concentrated under reduced pressure and the residue was purified by gradient column chromatography (gradient from 100% DCM to 10:1 DCM:MeOH). The obtained compound was re-purified by HPLC (gradient H2O →MeOH) to yield 5-(2-nitrobenzyloxy)methyl-2´-deoxycytidine (31 mg; 41%). The spectral data were in accordance with literature 1, 2 .
5-(2-Nitrobenzyloxy)methyl-2´-deoxycytidine triphosphate (dC NB TP)
Nucleoside dC NB (28 mg; 0.07 mmol) was dried for 15 minutes at 80 °C under vacuum. Subsequently, the vial with starting material was cooled to room temperature and proton sponge (15 mg; 0.07 mmol) was added. The content was evacuated again and suspended in trimethylphosphate (0.28 mL) at 0 °C under argon atmosphere. POCl3 (8 μL; 0.09 mmol) was added and the reaction mixture was then stirred at 0 °C for 1 hour. An ice-cooled solution of tri-n-butylammonium pyrophosphate (198 mg; 0.36 mmol) in anhydrous DMF (0.7 mL) was added to the reaction mixture. After 1 hour of stirring, the solution was quenched by addition of aqueous TEAB (2M, 2 mL). The solvents were evaporated in vacuum and the residue was co-distilled several times with water. The product was isolated on HPLC (linear gradient: 0.1M TEAB 100% H2O → 0.1M TEAB 100% MeOH → 100% MeOH), evaporated, co-distilled with water; converted into a sodium salt form (Dowex 50 in Na+ cycle) and lyophilized to yield dC NB TP as a white powder (10 mg; 21% 
5-(6-Nitropiperonyloxy)methyl-2´-deoxycytidine (dC NP )
Compound 2b (118 mg, 0.18 mmol) was dissolved in dry THF, triethylamine trihydrofluoride (205 μL, 1.24 mmol) was added and the reaction was stirred overnight at rt in a plastic bottle. The solvent was removed under reduced pressure and the mixture was separated by chromatography (DCM:MeOH 7:1) to give dC NP as a yellow powder (30 mg, 39 %). 
5-(6-Nitropiperonyloxy)methyl-2´-deoxycytidine triphosphate (dC NP TP)
Nucleoside dC NP (12 mg, 0.03 mmol) and proton sponge (12 mg, 0.06 mmol) were suspended in trimethyl phosphate (80 µL) in an argon purged flask and the suspension was cooled to 0 °C. Then, redistilled POCl3 (5 µL, 0.06 mmol) was added. The reaction mixture was stirred at 0 °C for 40 min and then ice-cold solution of (NHBu3)2H2P2O7 (77 mg, 0.11 mmol) and tributyl amine (28 µL, 0.12 mmol) in anhydrous DMF (2 mL) was added. The reaction mixture was stirred at 0 °C for another 1 h. Then aqueous solution of TEAB (2M, 2 mL, 4 mmol) was added and the mixture was evaporated under reduced pressure. The residue was co-evaporated several times with water. The product was purified by HPLC chromatography (0.1 M aq. TEAB 050 % methanol), co-evaporated several times with water and converted to sodium salt on Dowex. Triphosphate (4.2 mg, 21 %) was obtained as a yellowish lyophilizate (water). 
MALDI analysis of PEX products
The reaction mixture (100 μL) contained KOD XL DNA polymerase (2.5 U/μL, 0.2 μL), GTP (1 mM, 21 μL), dCTP or modified dCTP (1 mM, 25 μL), primer 248sh (10 µM, 3.2 μL), 19-mer biotinylated template oligo1C (100 µM, 3.2 μL) and 10x buffer for KOD XL DNA polymerase (10 μL) supplied by the manufacturer. Reaction mixtures were incubated for 40 min at 60 °C in a thermomixer. After reaction, samples were purified on magnetic beads and MALDI was measured. 
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Kinetics of single modification incorporation by PEX
KOD XL DNA polymerase
The reaction mixture (20 μL) contained KOD XL DNA polymerase (2.5 U/μL, 0.02 μL), dCTP or modified dCTP (1 mM, 0.8 μL), 6-FAM labelled primer 248sh (3 µM, 1 μL), 19-mer oligo1C template (3 µM, 1.5 μL) and 10x buffer for KOD XL DNA polymerase ( 
Vent exo-DNA polymerase
The reaction mixture (20 μL) contained Vent exo-DNA polymerase (2.5 U/μL, 0.08 μL), dCTP or modified dCTP (1 mM, 0.8 μL), 6-FAM labelled primer 248sh (3 µM, 1 μL) and 19-mer oligo1C template (3 µM, 1.5 μL) and 10x buffer for KOD XL DNA polymerase (2 μL 
Multiple modification incorporation by PEX
The reaction mixture (20 μL) contained KOD XL DNA polymerase (2.5 U/μL, 0.02 μL), dNTPs (1mM, 1.5 μL or 3 μL for C NB TP and C NP TP), primer 248sh (3 µM, 1 μL), 31-mer template prb4basII (3 µM, 1.5 μL) and 10x buffer for KOD XL DNA polymerase (2 μL) supplied by the manufacturer. Reaction mixtures were incubated for 40 min at 60 °C in a thermomixer. After 
MALDI analysis of PEX products
The reaction mixture (100 μL) contained KOD XL DNA polymerase (2.5 U/μL, 0.2 μL), dNTPs (1mM, 21 μL or 25 μL for modified dCTP), primer 248sh (10µM, 3.2 μL) and biotinylated 31-mer template prb4basII (100µM, 3.2 μL) and 10x buffer for KOD XL DNA polymerase (10 μL) supplied by the manufacturer. Reaction mixtures were incubated for 40 min at 60 °C in a thermomixer. After reaction samples were purified on magnetic beads and MALDI was measured. The reaction mixtures (40 µL each) contained Pwo DNA polymerase (Peqlab, 1 U/µL, 0.4 μL), natural dNTPs (4 mM, 2 µL), functionalized-dCTP (4 mM, 2 µL), FAM-labelled primer 248sh (3µM, 2 µL), and 30-mer template KpC, PvC or ScC (3µM, 3 µL) in Pwo reaction buffer (4 µL) supplied by the manufacturer. Reaction mixtures were incubated for 30 min at 60 °C in a thermomixer. Subsequently, the each reaction mixture was divided into two portions. The first one was denatured by addition of stop solution (20 µL) and heated 5 min at 95 °C. The second portion was used in the study of cleavage by restriction endonucleases.
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PEX procedure for templates AflC, EcC, RsC
The reaction mixtures (40 µL each) contained Pwo DNA polymerase (Peqlab, 1 U/µL, 0.26 μL), natural dNTPs (4 mM, 0.5 µL), functionalized-dCTP (4 mM, 1 µL), FAM-labelled primer 248sh (3 µM, 2 µL), and 30-mer template AflC, EcC or RsC (3 µM, 3 µL) in Pwo reaction buffer (4 µL) supplied by the manufacturer. Reaction mixtures were incubated for 30 min at 60 °C in a thermomixer. Subsequently, the each reaction mixture was divided into two portions. The first one was denatured by addition of stop solution (20 µL,) and heated 5 min at 95 °C. The second portion was used in the study of cleavage by restriction endonucleases.
Cleavage by restriction endonucleases-general procedure
The second portions of reaction mixtures after PEX experiment (20 µL each) were mixed with 2 µL of reaction buffer (buffer for KpnI -NEBuffer-1.1; EcoRI -EcoRIBuffer; for AflII, RsaI, PvuII and HF-ScaI CutSmart Buffer was used) supplied by the manufacturer, together with one of the restriction endonuclease (KpnI/ EcoRI/ AflII/ PvuII/ HF-ScaI -NewEngland Biolabs, 2U, 0.5 µL or 0.75 µL in the case of RsaI). Each reaction mixture was incubated at 37 °C for 60 min. The products of cleavage were denatured by addition of stop solution (20 µL) and heated for 5 min at 95 °C.
Figure S17: Primer extension experiment and study of cleavage by restriction endonucleases: lanes 1, P: primer; lanes 2, C + : positive control experiments (product of PEX with natural dNTPs); lanes 3, C -: negative control experiments (absence of natural dCTP); lanes 4, C hm product of PEX in the presence of dC hm TP and 3 other natural dNTPs; lanes 5, NB: product of PEX with dC NB TP and 3 other natural dNTPs; lanes 6, C + : product of PEX with natural dNTPs followed by cleavage with a RE (AflII/ EcoRI/ PvuII/ KpnI/ RsaI/ ScaI), lanes 7, C hm : product of PEX in the presence of dC hm TP and 3 other natural dNTPs followed by cleavage with a RE (AflII/ EcoRI/ KpnI/ PvuII/ RsaI/ ScaI); lanes 8, NB product of PEX with dC NB TP and 3 other natural dNTPs followed by cleavage with a RE (no cleavage).
PEX product interaction with restriction enzymes KpnI and RsaI
KpC template
The reaction mixture (20 μL) contained KOD XL DNA polymerase (2.5 U/μL, 0.02 μL), dNTPs (1mM, 0.5 μL or 1 μL for dC NB TP and dC NP TP), primer 248sh (3 µM, 1 μL), 30-mer template KpC (3 µM, 1.5 μL) and 10x buffer for KOD XL DNA polymerase (2 μL) supplied by the manufacturer. Reaction mixtures were incubated for 30 min at 60 °C in a thermomixer. 
RsC template
The reaction mixture (20 μL) contained KOD XL DNA polymerase (2.5 U/μL, 0.02 μL), dNTPs (1mM, 0.2 μL or 0.25 μL for dC NB TP and dC NP TP), primer 248sh (3 µM, 1 μL), 30-mer template RsC (3 µM, 1.5 μL) and 10x buffer for KOD XL DNA polymerase (2 μL) supplied by the manufacturer. Reaction mixtures were incubated for 30 min at 60 °C in a thermomixer. 
Uncaging
KpC template
The reaction mixture (20 μL) contained KOD XL DNA polymerase (2.5 U/μL, 0.02 μL), dNTPs (1mM, 0.5 μL or 1 μL for dC NB TP and dC NP TP), primer 248sh (3 µM, 1 μL), 30-mer template KpC (3 µM, 1.5 μL) and 10x buffer for KOD XL DNA polymerase (2 μL) supplied by the manufacturer. Reaction mixtures were incubated for 30 min at 60 °C in a thermomixer.
After reaction, samples were either: 
Experimental set-up for the UV irradiation:
The solution of photocaged DNA (20 µL) after PEX reaction was irradiated with UV LED mounted directly on the top of an opened Eppendorf vial (see the photograph below). The distance between the LED and the sample solution was approximately 3.6 cm. The irradiation at 8°C was performed for the particular time interval. In the next step, the irradiated dsDNA was treated with restriction endonuclease RsaI or KpnI under conditions described in the part b) and the product was finally denatured by addition of stop solution and followed by heating for 5 min at 95 °C.
RsC template
The reaction mixture (20 μL) contained KOD XL DNA polymerase (2.5 U/μL, 0.02 μL), dNTPs (1mM, 0.2 μL or 0.25 μL for dC NB TP and dC NP TP), primer 248sh (3 µM, 1 μL), 30-mer template RsC (3 µM, 1.5 μL) and 10x buffer for KOD XL DNA polymerase (2 μL) supplied by the manufacturer. Reaction mixtures were incubated for 30 min at 60 °C in a thermomixer.
After reaction samples were either: and three natural dNTPs; lane 6, hm: product of PEX with modified dC hm TP and three natural dNTPs after incubation with RE; lane 7, NB: product of PEX with modified dC NB TP and three natural dNTPs, lanes 8-11, NB: product of PEX with modified dC NB TP and three natural dNTPs after irradiation with UV LED followed by incubation with RE; lane 12, NP: product of PEX with modified dC NP TP and three natural dNTPs, lanes 13-16, NP: product of PEX with modified dC NP TP and three natural dNTPs after irradiation with UV LED followed by incubation with RE. TP and three natural dNTPs; lane 6, hm: product of PEX with modified dC hm TP and three natural dNTPs after incubation with RE; lane 7, NB: product of PEX with modified dC NB TP and three natural dNTPs, lanes 8-12 or 8-13, NB: product of PEX with modified dC NB TP and three natural dNTPs after irradiation with UV LED followed by incubation with RE; lane 13 or 14, NP: product of PEX with modified dC NP TP and three natural dNTPs, lanes 14-18 or 15-20, NP: product of PEX with modified dC NP TP and three natural dNTPs after irradiation with UV LED followed by incubation with RE. 
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PCR
98-mer
The reaction mixture (20 μL) contained KOD XL DNA polymerase (2.5 U/μL, 0.2 μL), dNTPs (5mM, 1.2 μL or modified dCTP 2.4 μL), primers LT20 (10 µM, 2 μL) and LT25TH (10 µM, 2 μL) and 98-mer template FVL-A (1 µM, 0.5 μL), 10x buffer for KOD XL DNA polymerase (2 μL) supplied by the manufacturer and MnCl2 (10 mM, 1 μL). After initial denaturation for 3 min at 94 °C, 30 PCR cycles were run under following conditions: denaturation for 1 min at 94 °C, annealing for 1 min at 51 °C, extension for 2 min at 72 °C. After final extension for 6 min at 72 °C, the reaction was stopped by cooling to 4 °C. PCR products were purified using Agencourt magnetic particles and 6× DNA Loading Dye (Thermo Scientific) was added to samples in ratio 1:5 (loading dye:sample). Samples were analyzed by agarose gel electrophoresis using 2 % agarose gel stained with GelRed™ (Biotium). The gel was run for 40 min at 120 V. 
311-mer
The reaction mixture (20 μL) contained KOD XL DNA polymerase (2.5 U/μL, 1.2 μL), dNTPs (5 mM, 0.6 μL), dCTP (5 mM, 0.6 μL or 1.2 μL for modified dCTP), primers P-FOR-ins100bp_P2 (20 µM, 3 μL) and P-REV-P/P2 (20 µM, 3 μL), 311-mer template (81 ng/µL, 0.44 μL) and 10x buffer for KOD XL DNA polymerase (2 μL) supplied by the manufacturer. After initial denaturation for 3 min at 94 °C, 40 PCR cycles were run under following conditions: denaturation for 1 min at 94 °C, annealing for 1 min at 68 °C, extension for 1.5 min at 75 °C. After final extension for 5 min at 75 °C, the reaction was stopped by cooling to 4 °C. PCR products were purified using Agencourt magnetic particles and 6× DNA Loading Dye (Thermo Scientific) was added to samples in ratio 1:5 (loading dye:sample). Samples were analyzed by agarose gel electrophoresis using 1.3% agarose gel stained with GelRed™ (Biotium). The gel was run for 70 min at 120 V. 
